ELXMFNova Eye Medical Limited

About Nova Eye Medical Limited (ELXMF)

Nova Eye Medical Limited (ELXMF) is a Medical Devices company headquartered in Mawson Lakes, SA, Australia whose shares trade over-the-counter on the Pink tier.

Ellex designs, develops, manufactures and sells innovative products that help eye surgeons around the world to effectively and efficiently treat eye disease. Ellex is a world leader in this field. Headquartered in Adelaide, Australia, Ellex has ophthalmic lasers and devices that treat glaucoma, retinal disease primarily caused by diabetes, secondary cataract vitreous opacities, as well as age-related macular degeneration. Manufacturing is carried out in Adelaide, Australia and Fremont, California. Sales and service directly to eye surgeons is conducted via subsidiary offices in Fremont, Minneapolis, Lyon, Berlin, and Tokyo. A network of more than 50 distribution partners around the world services other markets.

ELXMF key facts

Ticker symbol

ELXMF

Market tier

Pink

Sector

Healthcare

Industry

Medical Devices

Headquarters

Mawson Lakes, SA, Australia

Country of incorporation

AU

Year of incorporation

1987

Employees

280

Estimated market cap

$14.36M (as of May 9, 2025)

Shares outstanding

143,601,138

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Latest filing

Annual Report (Jun 30, 2019)

Nova Eye Medical Limited leadership

• Maria Maieli — CEO
• Kimberley Menzies — Group Financial Director, Company Secretary Manager, Company Secretary

Explore more: Medical Devices stocks · Healthcare sector · Pink stocks · OTC stocks starting with E